We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
eHealth's Guidance Update: Here's What a Strong AEP Signals
Read MoreHide Full Article
Key Takeaways
EHTH raised its 2025 guidance after a stable AEP, citing stronger MA performance and improved efficiency.
eHealth now sees $540-$560M revenues, $30-$45M GAAP income and $80-$95M adjusted EBITDA for 2025.
EHTH credits higher-quality direct channels, AI-driven marketing gains and rising LTV for the lift.
eHealth, Inc. (EHTH - Free Report) recently announced that it is raising its financial outlook for fiscal year 2025 after a stable Annual Enrollment Period (AEP) performance, especially in its Medicare business. Management now forecasts total revenue of roughly $540-$560 million, narrowed from prior guidance, and GAAP net income between $30-$45 million, which is noticeably higher than its earlier outlook.
The company also lifted its adjusted EBITDA range to approximately $80-$95 million, from the previous range of $60-$80 million. While operating cash flow is expected to be between roughly negative $25 million and zero, the overall picture reflects improved profitability and momentum.
The Zacks Consensus Estimate for 2025 bottom line is currently pegged at 29 cents per share, indicating 119% year-over-year improvement. The bottom line is expected to further jump to $1.88 per share in 2026.
Image Source: Zacks Investment Research
The reasons behind this updated outlook are stable enrollment results during AEP, a shift toward higher-quality direct branded channels, and the use of AI tools that boosted marketing efficiency and sales conversion. eHealth also noted that the lifetime value in the fourth quarter is expected to grow year-over-year because of higher commission rates and better persistency trends.
For eHealth, this means the company is gaining better profitability traction and operational discipline, strengthening confidence in execution after prior years of financial pressure. Investors will see this as a positive signal on growth and cost management trends.
This update shows eHealth is navigating a competitive Medicare market more effectively, using tech and channel strategy to drive results, and that its most important enrollment period can materially move the company’s full-year prospects.
How Are Other Health Insurers Faring?
Centene Corporation (CNC - Free Report) has been among the most volatile, reflecting its heavy exposure to ACA exchanges and Medicaid. However, tighter pricing discipline, better risk adjustment, a steadier regulatory backdrop and sustained enrollment in government programs should help CNC’s profitability recover over time. UnitedHealth Group Incorporated (UNH - Free Report) is also seeing margin pressure from elevated medical utilization, but its massive scale, diversified earnings and analytics-led cost controls provide resilience. With disciplined capital allocation and refreshed leadership, UNH remains well-positioned heading into 2026 as a durable, high-quality compounder. Longer-term visibility and execution discipline should continue to differentiate outcomes.
EHTH’s Price Performance & Valuation
Shares of eHealth have gained 7.3% over the past three months, outperforming the broader industry and the S&P 500 Index.
EHTH YTD Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, eHealth trades at a forward price-to-sales ratio of 0.25X, down from the industry average of 3.22X. Yet it carries a Value Score of C.
Image: Bigstock
eHealth's Guidance Update: Here's What a Strong AEP Signals
Key Takeaways
eHealth, Inc. (EHTH - Free Report) recently announced that it is raising its financial outlook for fiscal year 2025 after a stable Annual Enrollment Period (AEP) performance, especially in its Medicare business. Management now forecasts total revenue of roughly $540-$560 million, narrowed from prior guidance, and GAAP net income between $30-$45 million, which is noticeably higher than its earlier outlook.
The company also lifted its adjusted EBITDA range to approximately $80-$95 million, from the previous range of $60-$80 million. While operating cash flow is expected to be between roughly negative $25 million and zero, the overall picture reflects improved profitability and momentum.
The Zacks Consensus Estimate for 2025 bottom line is currently pegged at 29 cents per share, indicating 119% year-over-year improvement. The bottom line is expected to further jump to $1.88 per share in 2026.
The reasons behind this updated outlook are stable enrollment results during AEP, a shift toward higher-quality direct branded channels, and the use of AI tools that boosted marketing efficiency and sales conversion. eHealth also noted that the lifetime value in the fourth quarter is expected to grow year-over-year because of higher commission rates and better persistency trends.
For eHealth, this means the company is gaining better profitability traction and operational discipline, strengthening confidence in execution after prior years of financial pressure. Investors will see this as a positive signal on growth and cost management trends.
This update shows eHealth is navigating a competitive Medicare market more effectively, using tech and channel strategy to drive results, and that its most important enrollment period can materially move the company’s full-year prospects.
How Are Other Health Insurers Faring?
Centene Corporation (CNC - Free Report) has been among the most volatile, reflecting its heavy exposure to ACA exchanges and Medicaid. However, tighter pricing discipline, better risk adjustment, a steadier regulatory backdrop and sustained enrollment in government programs should help CNC’s profitability recover over time. UnitedHealth Group Incorporated (UNH - Free Report) is also seeing margin pressure from elevated medical utilization, but its massive scale, diversified earnings and analytics-led cost controls provide resilience. With disciplined capital allocation and refreshed leadership, UNH remains well-positioned heading into 2026 as a durable, high-quality compounder. Longer-term visibility and execution discipline should continue to differentiate outcomes.
EHTH’s Price Performance & Valuation
Shares of eHealth have gained 7.3% over the past three months, outperforming the broader industry and the S&P 500 Index.
EHTH YTD Price Performance
From a valuation standpoint, eHealth trades at a forward price-to-sales ratio of 0.25X, down from the industry average of 3.22X. Yet it carries a Value Score of C.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.